Search results for

Gilead Sciences has committed to donating the initial supply of the experimental antiviral drug. But executives said the company will need to make expanded production of the treatment sustainable.

There are various studies looking at changes to the virus genome — and the possible impact on how the virus affects humans. Here's what we know (and don't yet know) about mutations.

What do the latest unemployment rates mean for the U.S. economy? NPR's Noel King speaks with Heidi Shierholz of the Economic Policy Institute and Claudia Goldin of Harvard University.

Belarusian President Alexander Lukashenko has dismissed the pandemic as mass "psychosis" — a disease easily cured with a bit of vodka, a hot sauna or spending time playing hockey or doing farm work.

Two men, Gregory and Travis McMichael, have been charged with murder in connection with the killing of an unarmed black man in February. State officials say the investigation remains open.

Congress set aside $350 million to help colleges with "significant unmet needs" related to the pandemic. Most of that money has gone to small schools that serve just a fraction of U.S. students.

Companies around the country are figuring out how to safely reopen office during the pandemic. The new normal might involve smartphone apps and badges to track employees.

The procedural move gives attorneys for House Democrats until May 18 to respond. They say they're owed access to confidential evidence and other materials. No, argues the Trump administration.

A trio of Senate Democrats wants to give $2,000 per month to individuals through the end of the health emergency. One Senate Republican suggests covering payroll for companies that rehire workers.

Rick Bright, a top scientist working on a vaccine, says he was reassigned for not focusing on treatments favored by President Trump, even though they lacked "scientific merit."